If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

The programme – spearheaded by The Academic Respiratory Initiative for Pulmonary Health (Tariph) Centre under LKCMedicine – ...

Researchers have identified new lung function and blood test cutoffs to improve timely chronic hypercapnia management in ...

Injurious falls are common among people with chronic obstructive pulmonary disease (COPD) in the two years before de ...

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

A recent study conducted by researchers from Seattle-based University of Washington and Durham, N.C.-based Duke University found a strong association between the use of fall-risk increasing drugs and ...

Study reveals the Prospector calculator reduces antibiotic prescriptions in COPD exacerbations, improving outcomes and ...

Among patients with COPD who experienced an exacerbation, the risk for cardiovascular events was highest in the following 2 weeks and stayed elevated more than 1 year after, according to study results ...

RS BioTherapeutics, whose mission is to develop life-changing medicines for the millions of people suffering from deadly lung diseases characterized by pulmonary inflammation, is pleased to announce ...

Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...